Novo Nordisk reported that anti-obesity drug sales grew by 124 percent in the first quarter of 2023, with the bulk of those sales taking place in the North American market
PubMed Central, Singla, Rajeev K., et al
In the tirzepatide trial, in which about half of participants lost 20% or more of their body weight on the higher doses of the drug (compared to the placebo group, where only 3% lost 20% or more of their body weight), about 9% of people lost less than 5%
The brand looks to set itself apart from other GLP-1 prescribers by offering more than 6 decades of weight loss experience: As a trusted, science-backed brand with over 60 years of history, we offer comprehensive weight health support that includes both behavioral, medication, registered dietitians, and fitness. WeightWatchers Clinic is adapting to the changing weight loss medication climate by offering more affordable compounded medications as of October 2024